LifeMD Reports 13% Revenue Growth and 20% Adjusted EBITDA Increase in Q3 2025

Reuters

2025/11/18

LifeMD Reports 13% Revenue Growth and 20% Adjusted EBITDA Increase in Q3 2025

LifeMD Inc. reported third quarter 2025 total revenue of $60.2 million, an increase of 13% year-over-year. Telehealth revenue rose 18% to $47.3 million, with the number of active telehealth subscribers up 14% to approximately 310,000. Adjusted EBITDA increased 20% to $5.1 million, and telehealth adjusted EBITDA grew 30% to $2.9 million. The company paid off all outstanding debt during the quarter and, subsequent to quarter end, fully divested its majority stake in WorkSimpli. LifeMD is now focused as a pure-play telehealth and pharmacy platform, with continued diversification of its clinical offerings, including new launches in women's health, men's health, and psychiatry. For full-year 2025, LifeMD expects revenue between $192.0 million and $193.0 million, up approximately 24% from 2024, and adjusted EBITDA between $13.5 million and $14.5 million, an increase of about 254% versus 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-023853), on November 17, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2584671041"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2584671041\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2584671041?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-18 05:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584671041","market":"fut","top_or_hot":-1,"title":"LifeMD Reports 13% Revenue Growth and 20% Adjusted EBITDA Increase in Q3 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      LifeMD Reports 13% Revenue Growth and 20% Adjusted EBITDA Increase in Q3 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/LFMD\">LifeMD Inc.</a> reported third quarter 2025 total revenue of $60.2 million, an increase of 13% year-over-year. Telehealth revenue rose 18% to $47.3 million, with the number of active telehealth subscribers up 14% to approximately 310,000. Adjusted EBITDA increased 20% to $5.1 million, and telehealth adjusted EBITDA grew 30% to $2.9 million. The company paid off all outstanding debt during the quarter and, subsequent to quarter end, fully divested its majority stake in WorkSimpli. LifeMD is now focused as a pure-play telehealth and pharmacy platform, with continued diversification of its clinical offerings, including new launches in women's health, men's health, and psychiatry. For full-year 2025, LifeMD expects revenue between $192.0 million and $193.0 million, up approximately 24% from 2024, and adjusted EBITDA between $13.5 million and $14.5 million, an increase of about 254% versus 2024.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/LFMDP\">LifeMD Inc.</a> published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-023853), on November 17, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LifeMD Reports 13% Revenue Growth and 20% Adjusted EBITDA Increase in Q3 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLifeMD Reports 13% Revenue Growth and 20% Adjusted EBITDA Increase in Q3 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-18 05:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      LifeMD Reports 13% Revenue Growth and 20% Adjusted EBITDA Increase in Q3 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/LFMD\">LifeMD Inc.</a> reported third quarter 2025 total revenue of $60.2 million, an increase of 13% year-over-year. Telehealth revenue rose 18% to $47.3 million, with the number of active telehealth subscribers up 14% to approximately 310,000. Adjusted EBITDA increased 20% to $5.1 million, and telehealth adjusted EBITDA grew 30% to $2.9 million. The company paid off all outstanding debt during the quarter and, subsequent to quarter end, fully divested its majority stake in WorkSimpli. LifeMD is now focused as a pure-play telehealth and pharmacy platform, with continued diversification of its clinical offerings, including new launches in women's health, men's health, and psychiatry. For full-year 2025, LifeMD expects revenue between $192.0 million and $193.0 million, up approximately 24% from 2024, and adjusted EBITDA between $13.5 million and $14.5 million, an increase of about 254% versus 2024.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/LFMDP\">LifeMD Inc.</a> published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-023853), on November 17, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4183","symbol_name":"个人用品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDLbbkmtS:1","article_id":"2584671041","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584671041","pubTimestamp":1763413898,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"LifeMD Inc. reported third quarter 2025 total revenue of $60.2 million, an increase of 13% year-over-year. Telehealth revenue rose 18% to $47.3 million, with the number of active telehealth subscribers up 14% to approximately 310,000. Adjusted EBITDA increased 20% to $5.1 million, and telehealth adjusted EBITDA grew 30% to $2.9 million. The company paid off all outstanding debt during the quarter and, subsequent to quarter end, fully divested its majority stake in WorkSimpli. LifeMD is now focused as a pure-play telehealth and pharmacy platform, with continued diversification of its clinical offerings, including new launches in women's health, men's health, and psychiatry. For full-year 2025, LifeMD expects revenue between $192.0 million and $193.0 million, up approximately 24% from 2024, and adjusted EBITDA between $13.5 million and $14.5 million, an increase of about 254% versus 2024.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4183":"个人用品","BK4167":"医疗保健技术","LFMD":"LifeMD Inc."},"translate_title":"LifeMD报告2025年第三季度收入增长13%，调整后EBITDA增长20%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFMD":0.9},"content_text":"LifeMD Reports 13% Revenue Growth and 20% Adjusted EBITDA Increase in Q3 2025\n    \n\nLifeMD Inc. reported third quarter 2025 total revenue of $60.2 million, an increase of 13% year-over-year. Telehealth revenue rose 18% to $47.3 million, with the number of active telehealth subscribers up 14% to approximately 310,000. Adjusted EBITDA increased 20% to $5.1 million, and telehealth adjusted EBITDA grew 30% to $2.9 million. The company paid off all outstanding debt during the quarter and, subsequent to quarter end, fully divested its majority stake in WorkSimpli. LifeMD is now focused as a pure-play telehealth and pharmacy platform, with continued diversification of its clinical offerings, including new launches in women's health, men's health, and psychiatry. For full-year 2025, LifeMD expects revenue between $192.0 million and $193.0 million, up approximately 24% from 2024, and adjusted EBITDA between $13.5 million and $14.5 million, an increase of about 254% versus 2024.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-023853), on November 17, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}